Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Diprophylline |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Ambuphylline |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Leukotriene receptor antagonist |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Theophylline (substance) |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Aminophylline (substance) |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 125 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 160 mg/15 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 100 mg/15 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 50 mg/1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 400 mg/10 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 100 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 675 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 575 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 50 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline 200 mg and guaifenesin 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 600 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing diprophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Diprophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
dyphyllin 300 mg + guaifenesin 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 100 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin 1200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 300 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 600 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
respirationsmuskelrelakserende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
5-lipoxygenase inhibitor |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
xanthinbronchodilator |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|
Zileuton |
Is a |
False |
respirationsmuskelrelakserende middel |
Inferred relationship |
Some |
|